نمایش مختصر رکورد

dc.contributor.authorWidmer, Philippeen_US
dc.contributor.authorZweifel, Peteren_US
dc.date.accessioned1399-07-08T18:17:30Zfa_IR
dc.date.accessioned2020-09-29T18:17:31Z
dc.date.available1399-07-08T18:17:30Zfa_IR
dc.date.available2020-09-29T18:17:31Z
dc.date.issued2016-11-01en_US
dc.date.issued1395-08-11fa_IR
dc.date.submitted2016-07-25en_US
dc.date.submitted1395-05-04fa_IR
dc.identifier.citationWidmer, Philippe, Zweifel, Peter. (2016). Unintended Consequences of Hospital Payment: The Case of Swiss Diagnosis Related Groups. Hospital Practices and Research, 1(4), 105-113. doi: 10.21859/hpr-0104105en_US
dc.identifier.issn2476-390X
dc.identifier.issn2476-3918
dc.identifier.urihttps://dx.doi.org/10.21859/hpr-0104105
dc.identifier.urihttp://www.jhpr.ir/article_34223.html
dc.identifier.urihttps://iranjournals.nlai.ir/handle/123456789/40631
dc.description.abstract<strong>Background:</strong> In 2012, Switzerland changed from retrospective to prospective hospital payment based on diagnosis related groups (DRGs), following the example of the United States, Australia, and Germany. As in these countries, the objective of this transition was to motivate hospitals to improve efficiency by making them bear financial risk to some extent.<br /><strong>Objective:</strong> This contribution seeks to find out whether SwissDRG, the Swiss version of DRG payment, indeed provides hospitals with appropriate incentives, thus creating a level playing field enabling workable competition between them.<br /><strong>Methods:</strong> Three conditions for creating a level playing are stated, of which the first is tested using data on some 757 000 patient cases treated by 93 hospitals in the year 2012.<br /><strong>Results:</strong> The evidence suggests that hospital payment as currently devised by SwissDRG fails to create a level playing field. Differences in margins over cost of treatment can be traced to a hospital's portfolio of specialties and mix of patients, both of which are largely beyond their control. The findings of this paper are subject to several limitations. The true DRG-specific cost distributions (and hence expected values) are not known; moreover, emphasis has been on variable cost, neglecting fixed (capital user) cost. Finally, hospitals with a high amount of capital user cost may well benefit from modern technology contributing to their efficiency in terms of variable cost.<br /><strong>Conclusion:</strong> The finding that current hospital financing by SwissDRG fails to create a level playing field is likely to be robust, calling for an expeditious adjustment be-cause hospitals are exposed to financial risk to a greatly differing degree. It may be appropriate for them to purchase insurance against their financial risk, which is largely driven by influences beyond their control.en_US
dc.format.extent436
dc.format.mimetypeapplication/pdf
dc.languageEnglish
dc.language.isoen_US
dc.publisherBaqiyatallah University of Medical Sciencesen_US
dc.relation.ispartofHospital Practices and Researchen_US
dc.relation.isversionofhttps://dx.doi.org/10.21859/hpr-0104105
dc.subjectHospital financingen_US
dc.subjectDRG paymenten_US
dc.subjectCost efficiencyen_US
dc.subjectFinancial risken_US
dc.subjectIncentive problemsen_US
dc.titleUnintended Consequences of Hospital Payment: The Case of Swiss Diagnosis Related Groupsen_US
dc.typeTexten_US
dc.typeReview Articleen_US
dc.contributor.departmentSenior Health Economist, Polynomics AG, Baslerstr. 60, 4600 Olten, Switzerlanden_US
dc.contributor.departmentDepartment of Economics, University of Zurich, Switzerlanden_US
dc.citation.volume1
dc.citation.issue4
dc.citation.spage105
dc.citation.epage113


فایل‌های این مورد

Thumbnail

این مورد در مجموعه‌های زیر وجود دارد:

نمایش مختصر رکورد